definiens: means [ * * * ] . Mpex and [COMPANY] acknowledge that Mpex ha s not been provided with a copy of the Third Party License Agreement . 1.47 means the activities, deliverables, timelines, Specifications and budget for the Projec t, established by the Parties pursuant to Section 2.2 . In addition, the following terms shall have the meaning described in the corresponding section of this Agreement . Other term s may be defined throughout the Agreement . Term Section Term Section AAA 14.2 Notic e to Abandon [COMPANY] Actual Royalty Rates 6.6 Configuration 4.4 Agreement Preamble [COMPANY] Preamble [ * * * ] 1.20 [COMPANY] Background Patents 6.2.1(a ) [ * * * ] Certain informati on in this document has been omitted and filed separately with the Securities and Exchange C ommission Confidential treatment has been requested with respect to portions of this agr eement . 7 Term Section Term Section [ * * * ] 6.5(a ) [COMPANY] Background Intellectual billable - hour 1 .40(c ) Property 6.4(a ) CEO ’s 2.3.5 [COMPANY] Competitor 4.1.3 Commercial Supply Agreement 7.5 [ * * * ] 1.20 Defaulted Claims 3.4 Project Data 1.7(a ) Development Phase 2.1 Projected Royalty Period 6.6(d)(ii ) Disputing Party Notice 14.1 Panel 14.2(a ) Effective Date Preamble P arty, Parties Preamble Enforcement Action 10.3 Patent Rights 1.18(a ) Existing [COMPANY] Dat a 1.7(b ) Primary Program 4.4 Existing Nebulizer 3.2(c ) Priority Party 10.3(c ) Extended Ex clusive Period 4.2(c ) Project Fees 2.6 Failure Event Exhibit 7.5 Project Fee Default 3.4 F easibility Phase 2.1 Project Results 3.1 Field Infringement 10.3 Project Patents 3.2 First E xclusive Period 4.2(a ) Project Patent Infringement 10.3 IND 4.2(c ) Reduction Effective Da te 6.6(d)(i ) Know - how 1.18 Regulatory Filings 7.4 Litigation Agreement 10.3 Requesting Pa rty 10.3(c ) Mpex Preamble Response 14.1 Mpex Background Formulation 6.4(a ) [ * * * ] 4.2(b ) Mpex Background Intellectual Royalty Buydown Floor 6.6 Property 6.4(a ) Second Ex clusive Period 4.2(b ) Mpex Background Patents 6.2.1(a ) Sinusitis Field 4.3 Net Present Value 6.6(d)(iii ) Stated Royalty Rates 6.6 Non - Royalty Components 6.4(b ) Technical A ctivity, R&D Personnel 1.40(a ) Non - Technical Activities 1.40(b ) Third Party IP 6.4(a ) Article 2 - Development Project 2.1 Scope of the Project . Subject to the terms and conditions of this Agreement, the Parties shall collaborate, in accordance with one or more Work Pl an(s ): ( a ) to evaluate and/or create formulation(s ) of compound(s ) in the Mpex Field for pulmonary delivery, with the goal of defining a Drug Product and Licensed Configuration which is ready for further clinical development ( ), and ( b ) to devel op and obtain Marketing Approval for such Licensed Configuration in the Mpex Territory ( ) . 2.2 Work Plans